Table 3.
Total TEAE by severity.
Oxaloacetate (N = 42) | Control (N = 40) | |
---|---|---|
Total number of TEAEs | 41 | 40 |
Number (%) of participants reporting at least one | ||
TEAE | 22 (52.4%) | 16 (40.0%) |
Serious TEAE | 0 | 3 (7.5%) |
Related TEAE | 12 (28.6%) | 7 (17.5%) |
Maximum severity | ||
Mild | 10 (23.8%) | 5 (12.5%) |
Moderate | 11 (26.2%) | 5 (12.5%) |
Severe | 2 (4.8%) | 6 (15.0%) |